Published in J Cardiovasc Transl Res on November 20, 2015
Pharmacogenomics of the Natriuretic Peptide System in Heart Failure. Curr Heart Fail Rep (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Controlling the false discovery rate in behavior genetics research. Behav Brain Res (2001) 21.82
The comparison of percentages in matched samples. Biometrika (1950) 8.93
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA (2002) 5.19
Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet (2009) 3.81
Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation (2005) 3.48
Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA (2005) 3.37
GATES: a rapid and powerful gene-based association test using extended Simes procedure. Am J Hum Genet (2011) 3.34
Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet (2012) 2.09
Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol (2006) 1.98
Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation (2003) 1.42
Genetic variation in the B-type natiuretic peptide pathway affects BNP levels. Cardiovasc Drugs Ther (2007) 1.18
Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure. Heart Dis (2003) 1.03
The effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assays. Mayo Clin Proc (2011) 0.99
Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). Eur J Heart Fail (2014) 0.98
A novel missense mutation of exon 3 in the type A human natriuretic peptide receptor gene: possible association with essential hypertension. Hypertens Res (2002) 0.90
The genetic contribution of the natriuretic peptide system to cardiovascular diseases. Endocr J (2005) 0.89
Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure. J Card Fail (2010) 0.89
Genetic variation in the natriuretic peptide system and heart failure. Heart Fail Rev (2008) 0.89
Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: an exploratory study. Circ Heart Fail (2011) 0.88
Heart failure biomarkers. J Cardiovasc Transl Res (2013) 0.87
A novel variable number of tandem repeat of the natriuretic peptide precursor B gene's 5'-flanking region is associated with essential hypertension among Japanese females. Int J Med Sci (2007) 0.82
BNP and Heart Failure: Preclinical and Clinical Trial Data. J Cardiovasc Transl Res (2015) 0.80
Association of genetic variation with gene expression and protein abundance within the natriuretic peptide pathway. J Cardiovasc Transl Res (2013) 0.79
Genetic and nongenetic factors influencing pharmacokinetics of B-type natriuretic peptide. J Card Fail (2014) 0.77